Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | NK-CAR immunotherapy development over the past 12 months

Evelyn Ullrich, MD, PhD, Goethe University Frankfurt, Frankfurt, Germany, talks on the development of NK-CAR immunotherapy over the past 12 months and important routes for further study. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.